glp-1 weight loss long-term Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness The Real Reason GLP-1 Weight

Although body composition analysis revealed a reduction in body weight, skeletal muscle mass remained unchanged

Makers of these unapproved tirzepatides and semaglutides are trying to cash in on the demand of these weight loss medications by peddling potentially dangerous substances

Considering these findings observed across a large, real-world cohort, the researchers concluded that avoidance of semaglutide based solely on concerns regarding the risk of NAION may not be warranted, as its potential benefits for blood glucose control and cardiovascular health likely outweigh its potential risks.

Endoscopy data also support concern for retained gastric contents

, , , , .

What comorbidities